- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04019691
Comparing the Visual Outcome, Visual Quality, and Satisfaction Among Three Types of Multi-focal Intraocular Lenses
May 9, 2022 updated by: Samsung Medical Center
The investigators are going to Investigate the comparative efficacy of the patients who underwent cataract surgery with three different multifocal IOLs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Going to analyze the clinical results of 60 patients who underwent bilateral cataract surgery and multifocal IOL implantation.
The patients were divided into the following three groups: Mix-and-Match, EDOF, and Trifocal.
The clinical assessments included uncorrected near, intermediate, distance and best corrected distance visual acuity, defocus curves, contrast sensitivity, and reading speed.
Patient satisfaction was evaluated by questionnaire.
All outcomes were compared among the three groups.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with bilateral senile cataracts and the desire to be spectacle-free for all distances
Exclusion Criteria:
- Patients younger than 21 years, had corneal astigmatism >1.00 D, previous ocular surgery or trauma, or ocular disease other than cataracts
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Mix-and-Match group
Cataract surgery and implantation of a Tecnis ZKB00 multifocal IOL with +2.75 D add power (Abbott Medical Optic Inc., Santa Ana, CA) in the dominant eye, and a Tecnis ZLB00 multifocal IOL with +3.25 D add power (Abbott Medical Optics Inc.) in the non-dominant eye.
|
Phacoemulsification and implantation of Tecnis ZKB00 multifocal IOL with +2.75 D add power (Abbott Medical Optic Inc., Santa Ana, CA) in the dominant eye, and a Tecnis ZLB00 multifocal IOL with +3.25 D add power (Abbott Medical Optics Inc.) in the non-dominant eye.
|
Active Comparator: EDOF group
Cataract surgery and implantation of Tecnis Symfony ZXR00 trifocal IOLs (Abbot Medical Optics Inc.) in both eyes.
|
Phacoemulsification and implantation of Tecnis Symfony ZXR00 trifocal IOLs (Abbot Medical Optics Inc.) in both eyes.
|
Active Comparator: Trifocal group
Cataract surgery and implantation of FineVision PodFT IOLs (PhysIOL SA) in both eyes.
|
Phacoemulsification and implantation of FineVision PodFT IOLs (PhysIOL SA) in both eyes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative uncorrected near, intermediate, and far visual acuity.
Time Frame: At 1month and 3months after surgery
|
logMAR
|
At 1month and 3months after surgery
|
Postoperative contrast sensitivity in the three groups.
Time Frame: Postoperative 3 months
|
3, 6, 12, and 18 cycles per degree using a CSV-1000 chart (Vector Vision, reenville, OH) under photopic (85 cd/m2), mesopic (~3 cd/m2), and mesopic with glare conditions
|
Postoperative 3 months
|
Postoperative satisfaction questionnaire.
Time Frame: Postoperative 3 months
|
patients were shown images and asked to rate the frequency, degree, and discomfort related to the visual artifacts as none, minimal, moderate, or severe (0, 1, 2, or 3 points for the respective levels).
The mean score was calculated.
|
Postoperative 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative refractive outcome
Time Frame: Postoperative 3 months
|
Diopter
|
Postoperative 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Actual)
April 7, 2019
Study Completion (Actual)
June 26, 2020
Study Registration Dates
First Submitted
July 10, 2019
First Submitted That Met QC Criteria
July 12, 2019
First Posted (Actual)
July 15, 2019
Study Record Updates
Last Update Posted (Actual)
May 13, 2022
Last Update Submitted That Met QC Criteria
May 9, 2022
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMC 2019-06-017-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Mix-and-Match
-
University of Massachusetts, AmherstPatient-Centered Outcomes Research Institute; University at Albany; Psychological... and other collaboratorsCompletedMental IllnessUnited States
-
Rutgers, The State University of New JerseyCompleted
-
Harvard UniversityCompletedDepression | Anxiety | Trauma | Behavior ProblemsUnited States
-
Sun Farm CorporationNational Center for Complementary and Integrative Health (NCCIH)UnknownNon-small Cell Lung CancerUnited States
-
NestléGreat Ormond Street Hospital for Children NHS Foundation TrustCompleted
-
Duke UniversitySociety of American Gastrointestinal and Endoscopic SurgeonsWithdrawn
-
Steno Diabetes Center CopenhagenDSM Nutritional Products, Inc.CompletedType 1 Diabetes | Diabetic Kidney Disease | Albuminuria | NephropathyDenmark
-
Prollergy dba Ready Set FoodObvioHealthNot yet recruitingFood Allergy in Infants
-
Hebei Medical UniversityCompletedAneurysmal Subarachnoid HemorrhageChina
-
ALK-Abelló A/SCompleted